FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Olga Gurevitch

Research Profile

Procedures

Living Beings

Physiology

Chemicals & Drugs

Cyclophosphamide

Disorders

Graft vs Host Disease

Anatomy

Co-author Network

Publications

TOP 3
Raphael Gorodetsky; Olga Gurevitch; Lilia Levdansky; Esther Lubzens; Elena Gaberman; William H McBride
Fibrin microbeads loaded with mesenchymal cells support their long-term survival while sealed at room temperature.
Gregory Elkin; Olga Gurevitch; Sofia Khitrin; Tatyana B Prigozhina; Shimon Slavin; Igor B Resnick
Visualization of immune response kinetics in full allogeneic chimeras.
Olga Gurevitch; Shimon Slavin; Igor B Resnick; Sofia Khitrin; A Feldman
Mesenchymal progenitor cells in red and yellow bone marrow.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Olga Gurevitch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Raphael Gorodetsky; Olga Gurevitch; Lilia Levdansky; Esther Lubzens; Elena Gaberman; William H McBride
Fibrin microbeads loaded with mesenchymal cells support their long-term survival while sealed at room temperature.
Tissue engineering. Part C, Methods 2011;17(7):745-55.
2011: Gregory Elkin; Olga Gurevitch; Sofia Khitrin; Tatyana B Prigozhina; Shimon Slavin; Igor B Resnick
Visualization of immune response kinetics in full allogeneic chimeras.
American journal of blood research 2011;1(2):110-8.
2009: Olga Gurevitch; Shimon Slavin; Igor B Resnick; Sofia Khitrin; A Feldman
Mesenchymal progenitor cells in red and yellow bone marrow.
Folia biologica 2009;55(1):27-34.
2007: Olga Gurevitch; Shimon Slavin; Anatol G Feldman
Conversion of red bone marrow into yellow - Cause and mechanisms.
Medical hypotheses 2007;69(3):531-6.
2007: Olga Gurevitch; Sofia Khitrin; Andrei Valitov; Shimon Slavin
Osteoporosis of hematologic etiology.
Experimental hematology 2007;35(1):128-36.
2006: Olga Gurevitch; Shimon Slavin
The hematological etiology of osteoporosis.
Medical hypotheses 2006;67(4):729-35.
2004: Tatyana B Prigozhina; Gregory Elkin; Olga Gurevitch; Shoshana Morecki; Elena Yakovlev; Sofia Khitrin; Shimon Slavin
Depletion of alloantigen-primed lymphocytes overcomes resistance to allogeneic bone marrow in mildly conditioned recipients.
Blood cells, molecules & diseases 2004;33(3):238-47.
2003: Olga Gurevitch; Basan Gowda S Kurkalli; Tatyana B Prigozhina; Judith Kasir; Anna Gaft; Shimon Slavin
Reconstruction of cartilage, bone, and hematopoietic microenvironment with demineralized bone matrix and bone marrow cells.
Stem cells (Dayton, Ohio) 2003;21(5):588-97.
2003: Tatyana B Prigozhina; Olga Gurevitch; Gregory Elkin; Shoshana Morecki; Elena Yakovlev; Shimon Slavin
CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia effects of transplanted cells.
Experimental hematology 2003;31(1):81-8.
2002: Gregory Elkin; TB Prighozina; Olga Gurevitch; Shimon Slavin
Nonmyeloablative bone marrow transplantation based on deletion of host-anti-donor alloreactive cells prevents autoimmune insulitis and diabetes in nonobese diabetic mice.
Transplantation proceedings 2002;34(4):1303-6.
2002: Tatyana B Prigozhina; Olga Gurevitch; Shoshana Morecki; Elena Yakovlev; Gregory Elkin; Shimon Slavin
Nonmyeloablative allogeneic bone marrow transplantation as immunotherapy for hematologic malignancies and metastatic solid tumors in preclinical models.
Experimental hematology 2002;30(1):89-96.
2000: Shimon Slavin; Reuven Or; TB Prighozina; Olga Gurevitch; Memet Aker; S Panighari; M Shapira; Arnon Nagler
Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man.
Bone marrow transplantation 2000;25 Suppl 2():S54-7.
1999: Olga Gurevitch; Tatyana B Prigozhina; T Pugatsch; Shimon Slavin
Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment.
Transplantation 1999;68(9):1362-8.
1999: Tatyana B Prigozhina; Olga Gurevitch; Shimon Slavin
Nonmyeloablative conditioning to induce bilateral tolerance after allogeneic bone marrow transplantation in mice.
Experimental hematology 1999;27(10):1503-10.
1999: Shimon Slavin; TB Prighozina; Olga Gurevitch; J Zhu; D Gross; I Rabstein; Lola Weiss
New approaches for control of anti-self reactivity in type 1 diabetes mellitus and transplantation of pancreatic islets.
Journal of molecular medicine (Berlin, Germany) 1999;77(1):223-5.
1998: Shimon Slavin; Olga Gurevitch; TB Prighozina
Induction of bilateral transplantation tolerance to cellular and perfused allografts and xenografts with donor hematopoietic cells.
Annals of the New York Academy of Sciences 1998;862():37-44.
1998: Shimon Slavin; Olga Gurevitch; J Zhu; TB Prighozina
Deletion of donor-reactive cells followed by stem cell transplantation in recipients treated with total lymphoid-irradiation as a means for induction of transplantation tolerance to organ allografts and xenografts.
Transplantation proceedings 1998;30(8):4021-2.
1997: Tatyana B Prigozhina; Olga Gurevitch; J Zhu; Shimon Slavin
Induction of mixed hematopoietic chimerism and specific transplantation tolerance to allogeneic and xenogeneic grafts by selective elimination of donor-reactive host cells following nonmyeloablative conditioning.
Transplantation proceedings 1997;29(6):2644-6.
1997: Shimon Slavin; Lola Weiss; TB Prighozina; Olga Gurevitch; J Zhu; I Rabstein; D Gross
New approaches for control of anti-self-reactivity in type 1 diabetes and transplantation of pancreatic islets.
Transplantation proceedings 1997;29(4):1929-31.
1997: Tatyana B Prigozhina; Olga Gurevitch; J Zhu; Shimon Slavin
Permanent and specific transplantation tolerance induced by a nonmyeloablative treatment to a wide variety of allogeneic tissues: I. Induction of tolerance by a short course of total lymphoid irradiation and selective elimination of the donor-specific host lymphocytes.
Transplantation 1997;63(10):1394-9.
1996: Olga Gurevitch; Shimon Slavin; A Muhlrad; Arie Shteyer; D Gazit; M Chorev; M Vidson; Malka Namdar-Attar; E Berger; I Bleiberg; I Bab
Osteogenic growth peptide increases blood and bone marrow cellularity and enhances engraftment of bone marrow transplants in mice.
Blood 1996;88(12):4719-24.